Nabeel Badri

504 total citations
13 papers, 91 citations indexed

About

Nabeel Badri is a scholar working on Oncology, Pathology and Forensic Medicine and Neurology. According to data from OpenAlex, Nabeel Badri has authored 13 papers receiving a total of 91 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 4 papers in Pathology and Forensic Medicine and 3 papers in Neurology. Recurrent topics in Nabeel Badri's work include Global Cancer Incidence and Screening (3 papers), Peripheral Neuropathies and Disorders (2 papers) and Cancer Treatment and Pharmacology (2 papers). Nabeel Badri is often cited by papers focused on Global Cancer Incidence and Screening (3 papers), Peripheral Neuropathies and Disorders (2 papers) and Cancer Treatment and Pharmacology (2 papers). Nabeel Badri collaborates with scholars based in United States and Egypt. Nabeel Badri's co-authors include Alok Dwivedi, Luis A. Sánchez, Nabih Diab, Luis Alvarado, Matthew J. Hamilton, Zeina Nahleh, Crosby D. Rock, Zeina Nahleh, Gayathri Nagaraj and Andrés Alvarado and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and European Journal of Cancer.

In The Last Decade

Nabeel Badri

12 papers receiving 89 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nabeel Badri United States 5 50 25 20 20 10 13 91
Tara E. Soumerai United States 6 33 0.7× 16 0.6× 28 1.4× 6 0.3× 8 0.8× 11 73
Leslie E. Oldfield Canada 5 49 1.0× 39 1.6× 33 1.6× 12 0.6× 10 1.0× 15 113
Gayle DiLalla United States 6 64 1.3× 54 2.2× 10 0.5× 16 0.8× 14 1.4× 19 101
Hana Zahed France 5 41 0.8× 25 1.0× 15 0.8× 9 0.5× 12 1.2× 10 81
BK Smruti India 6 25 0.5× 14 0.6× 6 0.3× 16 0.8× 14 1.4× 11 74
Sharat Chopra United Kingdom 6 24 0.5× 19 0.8× 17 0.8× 9 0.5× 4 0.4× 9 81
H. Amash Italy 4 47 0.9× 38 1.5× 13 0.7× 9 0.5× 8 0.8× 5 64
Danielle Kwiatkowski United States 4 58 1.2× 18 0.7× 18 0.9× 5 0.3× 6 0.6× 4 80
Theresa Hayes Australia 6 61 1.2× 33 1.3× 22 1.1× 25 1.3× 4 0.4× 22 100
Ken Mastris Belgium 4 35 0.7× 31 1.2× 14 0.7× 9 0.5× 9 0.9× 6 84

Countries citing papers authored by Nabeel Badri

Since Specialization
Citations

This map shows the geographic impact of Nabeel Badri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nabeel Badri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nabeel Badri more than expected).

Fields of papers citing papers by Nabeel Badri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nabeel Badri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nabeel Badri. The network helps show where Nabeel Badri may publish in the future.

Co-authorship network of co-authors of Nabeel Badri

This figure shows the co-authorship network connecting the top 25 collaborators of Nabeel Badri. A scholar is included among the top collaborators of Nabeel Badri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nabeel Badri. Nabeel Badri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Badri, Nabeel, et al.. (2023). Challenges and opportunities for treating intrahepatic cholangiocarcinoma: targeted therapy. Hepatoma Research. 1 indexed citations
2.
Badri, Nabeel, Jason Zittel, Andrea Baran, et al.. (2023). Regorafenib in older adults with metastatic colorectal cancer: A multi-center, single arm phase II trial.. Journal of Clinical Oncology. 41(16_suppl). 12047–12047. 1 indexed citations
3.
Dunne, Richard F., Nabeel Badri, Marcus Smith Noel, et al.. (2022). Induction FOLFOX prior to CROSS chemoradiotherapy and surgery in patients with locally-advanced esophageal and gastroesophageal junction cancer: A phase II study.. Journal of Clinical Oncology. 40(4_suppl). 327–327. 2 indexed citations
4.
Yin, Chao, John L. Marshall, Kerrie B. Bouker, et al.. (2022). A phase I dose-escalation study of eryaspase in combination with modified FOLFIRINOX in locally advanced and metastatic pancreatic ductal adenocarcinoma: Interim update.. Journal of Clinical Oncology. 40(4_suppl). 581–581. 2 indexed citations
5.
Nahleh, Zeina, Hamid Mirshahidi, Gayathri Nagaraj, et al.. (2018). Disparities in breast cancer: a multi‐institutional comparative analysis focusing on American Hispanics. Cancer Medicine. 7(6). 2710–2717. 26 indexed citations
6.
Badri, Nabeel, et al.. (2018). Brentuximab vedotin demonstrates an objective response in a patient with refractory CD30+ primary mediastinal B-cell lymphoma. Journal of Cancer Research and Therapeutics. 16(1). 183–183. 3 indexed citations
7.
Nahleh, Zeina, et al.. (2018). Clinico-pathologic disparities of breast cancer in Hispanic/Latina women. Breast Disease. 37(3). 147–154. 9 indexed citations
8.
Badri, Nabeel, et al.. (2018). Abstract P6-10-04: “Disparities in breast cancer: A multi-institutional comparative analysis focusing on American Hispanics”. Cancer Research. 78(4_Supplement). P6–10. 1 indexed citations
9.
Badri, Nabeel, Alok Dwivedi, Luis Alvarado, et al.. (2018). Epithelial-Mesenchymal Transition Markers in Breast Cancer and Pathological Responseafter Neoadjuvant Chemotherapy. Breast Cancer Basic and Clinical Research. 12. 2220345578–2220345578. 31 indexed citations
10.
Badri, Nabeel, et al.. (2016). Seronegative Neuromyelitis Optica: A Case Report of a Hispanic Male. Case Reports in Neurology. 8(2). 102–107. 4 indexed citations
11.
Torabi, Alireza, et al.. (2016). Diffuse Large B-Cell Non-Hodgkin's Lymphoma and Osteosclerotic Myeloma with Features of Poems Syndrome. Baylor University Medical Center Proceedings. 29(3). 306–308. 2 indexed citations
12.
Dwivedi, Alok, et al.. (2016). Prevalence of low vitamin D in patients with breast cancer in a predominantly Hispanic population at the American Mexican border.. Journal of Clinical Oncology. 34(15_suppl). e12051–e12051.
13.
Vinholes, J., Fernando Palacios Salas, E. Mickiewicz, et al.. (2001). A phase III trial of taxotere and doxorubicin (AT) versus 5-fluorouracil, doxorubicin and cyclophosphamide (FAC) in patients with unresectable locally advanced breast cancer: an interim analysis. European Journal of Cancer. 37. S167–S167. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tara E. Soumerai Breakdown of academic impact, for papers by Leslie E. Oldfield Breakdown of academic impact, for papers by Gayle DiLalla Breakdown of academic impact, for papers by Hana Zahed Breakdown of academic impact, for papers by BK Smruti Breakdown of academic impact, for papers by Sharat Chopra Breakdown of academic impact, for papers by H. Amash Breakdown of academic impact, for papers by Danielle Kwiatkowski Breakdown of academic impact, for papers by Theresa Hayes Breakdown of academic impact, for papers by Ken Mastris
Rankless by CCL
2026